Protagenic Therapeutics, Inc. (PTIX)
OQB · Healthcare · Biotechnology
$0.87
-5.33%
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.6M
Shares Outstanding
1.8M
Exchange
OQB
Currency
USD
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (1.4M) | (1.2M) | (1.1M) | (925K) |
| Net Income | (1.4M) | (5.1M) | (869K) | 2.2M |
| Diluted EPS | $-2.75 | $-1.37 | $-0.47 | $1.14 |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (4.1M) | (3.6M) | (4.5M) | (5.7M) |
| Net Income | (4.5M) | (3.6M) | (5.0M) | (5.5M) |
| Diluted EPS | $-17.36 | $-11.48 | $-16.10 | $-15.82 |